TY - JOUR
T1 - The role of the hematologist/oncologist as a primary care provider
AU - Rypkema, S. W.
AU - Holcombe, R. F.
N1 - Funding Information:
From the Department of Medicine and Center for Excellence in Cancer Research, Treatment and Education, Louisiana State University Medical Center, Shreveport, Louisiana. Supported by the Center for Excellence in Cancer Research, Louisiana State University Medical Center, Shreveport, Louisiana. Correspondence: Randall F. Holcombe, MD, Associate Professor of Medicine and Microbiology & Immunology, LSU Medical Center 1501 Kings Highway, Shreveport, LA 71130-3932. '
PY - 1994
Y1 - 1994
N2 - To determine the role of the hematologist-oncologist as a primary care provider, a survey was administered to a consecutive sample of 238 hematology-oncology patients. Patients were selected at random from the outpatient hematology-oncology clinics at three institutions: 66.1% from a university medical center, 22.5% from a private hospital, and 11.4% from a health maintenance organization-affiliated clinic. A total of 73 (30.9%) respondents reported they would see their hematologist-oncologist (heme/onc) for routine illnesses, such as sinus or bladder infections. Of the respondents who did not have a family doctor, the percentage increased to 45.5%. Of those patients who had other medical problems, such as hypertension or diabetes, 46 (43.0%) were followed by their heme/onc for these other medical problems. If the respondent did not have a family doctor, the percentage increased to 66.0%. Patients at the university medical center more frequently did not have a family doctor and used their heme/onc for primary care to a greater degree than patients at the private hospital and health maintenance organization (HMO)-affiliated clinic. A total of 55.9% of the respondents reported having the best physician-patient relationship with their heme/onc, whereas only 8.5% had the best relationship with their family doctor. The heme/onc does provide primary care for their patients. If the patient does not have a family doctor, the amount of primary care administered by the heme/onc greatly increases. It is likely that patients rely on their heme/onc for this care because of the close physician-patient relationship that develops as a result of the frequent clinic visits required by many patients with cancer or blood disorders.
AB - To determine the role of the hematologist-oncologist as a primary care provider, a survey was administered to a consecutive sample of 238 hematology-oncology patients. Patients were selected at random from the outpatient hematology-oncology clinics at three institutions: 66.1% from a university medical center, 22.5% from a private hospital, and 11.4% from a health maintenance organization-affiliated clinic. A total of 73 (30.9%) respondents reported they would see their hematologist-oncologist (heme/onc) for routine illnesses, such as sinus or bladder infections. Of the respondents who did not have a family doctor, the percentage increased to 45.5%. Of those patients who had other medical problems, such as hypertension or diabetes, 46 (43.0%) were followed by their heme/onc for these other medical problems. If the respondent did not have a family doctor, the percentage increased to 66.0%. Patients at the university medical center more frequently did not have a family doctor and used their heme/onc for primary care to a greater degree than patients at the private hospital and health maintenance organization (HMO)-affiliated clinic. A total of 55.9% of the respondents reported having the best physician-patient relationship with their heme/onc, whereas only 8.5% had the best relationship with their family doctor. The heme/onc does provide primary care for their patients. If the patient does not have a family doctor, the amount of primary care administered by the heme/onc greatly increases. It is likely that patients rely on their heme/onc for this care because of the close physician-patient relationship that develops as a result of the frequent clinic visits required by many patients with cancer or blood disorders.
UR - https://www.scopus.com/pages/publications/0027970140
U2 - 10.1097/00000441-199412000-00010
DO - 10.1097/00000441-199412000-00010
M3 - Article
C2 - 7985726
AN - SCOPUS:0027970140
SN - 0002-9629
VL - 308
SP - 360
EP - 364
JO - American Journal of the Medical Sciences
JF - American Journal of the Medical Sciences
IS - 6
ER -